STAT+: Eli Lilly’s very bad day
Good morning. Today, we read about the implications of mRNA funding cuts on national security, see layoffs at gene-editing player Tune Therapeutics, and more. Why mRNA funding cuts are a…
Previous Post
STAT+: Pharmalittle: We’re reading about Trump and drug prices, an FDA plan for U.S. manufacturing, and more
Next Post
5 Hot FDA Approval Dates That Made Waves Across Therapeutic Areas in July
📢
Advertisement
300x250 Banner
Recent Content
COPD Biologics: Early Treatment Insights
Pulmonology • 2 hours ago
Antihypertensive Medication Guidelines
Cardiology • 4 hours ago
Juvenile Arthritis Care Transition
Rheumatology • 6 hours ago